nodes	percent_of_prediction	percent_of_DWPC	metapath
Tretinoin—Night blindness—Varenicline—nicotine dependence	0.0238	0.0406	CcSEcCtD
Tretinoin—Sensory disturbance—Varenicline—nicotine dependence	0.0181	0.0308	CcSEcCtD
Tretinoin—Facial paralysis—Varenicline—nicotine dependence	0.0176	0.0301	CcSEcCtD
Tretinoin—ALDH1A2—cardiovascular system—nicotine dependence	0.0164	0.0957	CbGeAlD
Tretinoin—Anger—Varenicline—nicotine dependence	0.0157	0.0268	CcSEcCtD
Tretinoin—CYP4A11—Fatty acids—CYP2A7—nicotine dependence	0.0152	0.0627	CbGpPWpGaD
Tretinoin—Abnormal behaviour—Varenicline—nicotine dependence	0.015	0.0257	CcSEcCtD
Tretinoin—VIIth nerve paralysis—Varenicline—nicotine dependence	0.0137	0.0233	CcSEcCtD
Tretinoin—Hoarseness—Varenicline—nicotine dependence	0.0127	0.0217	CcSEcCtD
Tretinoin—RXRG—cardiovascular system—nicotine dependence	0.0125	0.073	CbGeAlD
Tretinoin—CRABP1—midbrain—nicotine dependence	0.0124	0.0721	CbGeAlD
Tretinoin—Pancreatitis acute—Varenicline—nicotine dependence	0.0121	0.0207	CcSEcCtD
Tretinoin—ALDH1A1—cardiovascular system—nicotine dependence	0.012	0.0696	CbGeAlD
Tretinoin—Myositis—Varenicline—nicotine dependence	0.0114	0.0195	CcSEcCtD
Tretinoin—Suicide—Varenicline—nicotine dependence	0.0108	0.0184	CcSEcCtD
Tretinoin—ALDH1A1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0107	0.0439	CbGpPWpGaD
Tretinoin—CYP2C18—Xenobiotics—CYP2A7—nicotine dependence	0.0106	0.0435	CbGpPWpGaD
Tretinoin—RARRES1—brain—nicotine dependence	0.0105	0.0612	CbGeAlD
Tretinoin—CYP2A6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0104	0.0428	CbGpPWpGaD
Tretinoin—Suicide attempt—Varenicline—nicotine dependence	0.00987	0.0168	CcSEcCtD
Tretinoin—RXRG—midbrain—nicotine dependence	0.00979	0.057	CbGeAlD
Tretinoin—Completed suicide—Varenicline—nicotine dependence	0.00952	0.0163	CcSEcCtD
Tretinoin—ALDH1A1—midbrain—nicotine dependence	0.00934	0.0544	CbGeAlD
Tretinoin—NR0B1—brain—nicotine dependence	0.00905	0.0527	CbGeAlD
Tretinoin—Upset stomach—Varenicline—nicotine dependence	0.00855	0.0146	CcSEcCtD
Tretinoin—CYP2B6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00837	0.0345	CbGpPWpGaD
Tretinoin—Menstrual disorder—Varenicline—nicotine dependence	0.00822	0.014	CcSEcCtD
Tretinoin—ALDH1A2—brain—nicotine dependence	0.00807	0.047	CbGeAlD
Tretinoin—Suicidal ideation—Varenicline—nicotine dependence	0.00799	0.0136	CcSEcCtD
Tretinoin—Thrombosis—Varenicline—nicotine dependence	0.00791	0.0135	CcSEcCtD
Tretinoin—CRABP1—brain—nicotine dependence	0.00779	0.0453	CbGeAlD
Tretinoin—Hyperlipidaemia—Varenicline—nicotine dependence	0.00777	0.0133	CcSEcCtD
Tretinoin—Scotoma—Varenicline—nicotine dependence	0.00737	0.0126	CcSEcCtD
Tretinoin—Gingivitis—Varenicline—nicotine dependence	0.00714	0.0122	CcSEcCtD
Tretinoin—CYP2C8—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00709	0.0292	CbGpPWpGaD
Tretinoin—CRABP2—brain—nicotine dependence	0.00704	0.041	CbGeAlD
Tretinoin—CYP3A7—Xenobiotics—CYP2A7—nicotine dependence	0.00702	0.0289	CbGpPWpGaD
Tretinoin—RXRA—brain—nicotine dependence	0.00701	0.0408	CbGeAlD
Tretinoin—Dysphonia—Varenicline—nicotine dependence	0.00681	0.0116	CcSEcCtD
Tretinoin—Acne—Varenicline—nicotine dependence	0.00666	0.0114	CcSEcCtD
Tretinoin—Eye irritation—Varenicline—nicotine dependence	0.00656	0.0112	CcSEcCtD
Tretinoin—CYP2B6—Fatty acids—CYP2A7—nicotine dependence	0.00653	0.0269	CbGpPWpGaD
Tretinoin—CYP2A6—Xenobiotics—CYP2A7—nicotine dependence	0.00643	0.0265	CbGpPWpGaD
Tretinoin—Tenderness—Varenicline—nicotine dependence	0.00642	0.011	CcSEcCtD
Tretinoin—Aggression—Varenicline—nicotine dependence	0.00637	0.0109	CcSEcCtD
Tretinoin—Chest discomfort—Varenicline—nicotine dependence	0.00633	0.0108	CcSEcCtD
Tretinoin—RARB—brain—nicotine dependence	0.0063	0.0367	CbGeAlD
Tretinoin—RXRG—brain—nicotine dependence	0.00615	0.0358	CbGeAlD
Tretinoin—Lacrimation increased—Varenicline—nicotine dependence	0.00608	0.0104	CcSEcCtD
Tretinoin—Leukocytosis—Varenicline—nicotine dependence	0.00596	0.0102	CcSEcCtD
Tretinoin—Dysarthria—Varenicline—nicotine dependence	0.00592	0.0101	CcSEcCtD
Tretinoin—ALDH1A1—brain—nicotine dependence	0.00587	0.0342	CbGeAlD
Tretinoin—RXRB—brain—nicotine dependence	0.00579	0.0337	CbGeAlD
Tretinoin—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00577	0.0238	CbGpPWpGaD
Tretinoin—Musculoskeletal pain—Varenicline—nicotine dependence	0.00567	0.00968	CcSEcCtD
Tretinoin—ALDH1A1—Biological oxidations—CYP2A7—nicotine dependence	0.00566	0.0233	CbGpPWpGaD
Tretinoin—Photophobia—Varenicline—nicotine dependence	0.00526	0.00898	CcSEcCtD
Tretinoin—CYP2B6—Xenobiotics—CYP2A7—nicotine dependence	0.00519	0.0214	CbGpPWpGaD
Tretinoin—Dry eye—Varenicline—nicotine dependence	0.00517	0.00883	CcSEcCtD
Tretinoin—RARG—brain—nicotine dependence	0.00514	0.0299	CbGeAlD
Tretinoin—Oesophagitis—Varenicline—nicotine dependence	0.00512	0.00874	CcSEcCtD
Tretinoin—CYP3A5—Xenobiotics—CYP2A7—nicotine dependence	0.00507	0.0209	CbGpPWpGaD
Tretinoin—Mouth ulceration—Varenicline—nicotine dependence	0.00506	0.00864	CcSEcCtD
Tretinoin—CYP4A11—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00502	0.0207	CbGpPWpGaD
Tretinoin—CYP4A11—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00495	0.0204	CbGpPWpGaD
Tretinoin—RARA—brain—nicotine dependence	0.00483	0.0281	CbGeAlD
Tretinoin—Euphoric mood—Varenicline—nicotine dependence	0.00481	0.00822	CcSEcCtD
Tretinoin—CYP1A1—Xenobiotics—CYP2A7—nicotine dependence	0.00479	0.0198	CbGpPWpGaD
Tretinoin—Lymphadenopathy—Varenicline—nicotine dependence	0.00476	0.00813	CcSEcCtD
Tretinoin—Diabetes mellitus—Varenicline—nicotine dependence	0.00467	0.00798	CcSEcCtD
Tretinoin—Deafness—Varenicline—nicotine dependence	0.00454	0.00776	CcSEcCtD
Tretinoin—Eczema—Varenicline—nicotine dependence	0.00452	0.00772	CcSEcCtD
Tretinoin—Renal failure acute—Varenicline—nicotine dependence	0.0044	0.00752	CcSEcCtD
Tretinoin—CYP2C8—Xenobiotics—CYP2A7—nicotine dependence	0.00439	0.0181	CbGpPWpGaD
Tretinoin—CYP2C18—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00438	0.0181	CbGpPWpGaD
Tretinoin—CYP2C18—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00433	0.0178	CbGpPWpGaD
Tretinoin—Visual disturbance—Varenicline—nicotine dependence	0.00429	0.00732	CcSEcCtD
Tretinoin—Arthritis—Varenicline—nicotine dependence	0.00418	0.00714	CcSEcCtD
Tretinoin—Lethargy—Varenicline—nicotine dependence	0.00415	0.00708	CcSEcCtD
Tretinoin—Cerebrovascular accident—Varenicline—nicotine dependence	0.00415	0.00708	CcSEcCtD
Tretinoin—CYP4A11—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00407	0.0168	CbGpPWpGaD
Tretinoin—Osteoarthritis—Varenicline—nicotine dependence	0.00407	0.00694	CcSEcCtD
Tretinoin—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.00407	0.00694	CcSEcCtD
Tretinoin—Affect lability—Varenicline—nicotine dependence	0.004	0.00683	CcSEcCtD
Tretinoin—RXRA—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00398	0.0164	CbGpPWpGaD
Tretinoin—Psychotic disorder—Varenicline—nicotine dependence	0.00397	0.00678	CcSEcCtD
Tretinoin—Irritability—Varenicline—nicotine dependence	0.00388	0.00662	CcSEcCtD
Tretinoin—Mood swings—Varenicline—nicotine dependence	0.00385	0.00657	CcSEcCtD
Tretinoin—Dry skin—Varenicline—nicotine dependence	0.00373	0.00636	CcSEcCtD
Tretinoin—Nasopharyngitis—Varenicline—nicotine dependence	0.00364	0.00621	CcSEcCtD
Tretinoin—Gastritis—Varenicline—nicotine dependence	0.0036	0.00614	CcSEcCtD
Tretinoin—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.00358	0.0147	CbGpPWpGaD
Tretinoin—CYP2C18—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00355	0.0147	CbGpPWpGaD
Tretinoin—Abdominal distension—Varenicline—nicotine dependence	0.00354	0.00604	CcSEcCtD
Tretinoin—Dysphagia—Varenicline—nicotine dependence	0.00351	0.006	CcSEcCtD
Tretinoin—Asthma—Varenicline—nicotine dependence	0.00351	0.006	CcSEcCtD
Tretinoin—CYP2B6—cardiovascular system—nicotine dependence	0.0035	0.0204	CbGeAlD
Tretinoin—CYP2C9—cardiovascular system—nicotine dependence	0.00346	0.0202	CbGeAlD
Tretinoin—CYP2A6—brain—nicotine dependence	0.00341	0.0198	CbGeAlD
Tretinoin—Abdominal discomfort—Varenicline—nicotine dependence	0.00337	0.00575	CcSEcCtD
Tretinoin—Pollakiuria—Varenicline—nicotine dependence	0.00325	0.00554	CcSEcCtD
Tretinoin—RXRA—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00322	0.0133	CbGpPWpGaD
Tretinoin—Photosensitivity reaction—Varenicline—nicotine dependence	0.00321	0.00548	CcSEcCtD
Tretinoin—Weight increased—Varenicline—nicotine dependence	0.0032	0.00546	CcSEcCtD
Tretinoin—Infestation—Varenicline—nicotine dependence	0.00313	0.00535	CcSEcCtD
Tretinoin—Infestation NOS—Varenicline—nicotine dependence	0.00313	0.00535	CcSEcCtD
Tretinoin—Depression—Varenicline—nicotine dependence	0.00312	0.00533	CcSEcCtD
Tretinoin—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.00311	0.0053	CcSEcCtD
Tretinoin—Acute coronary syndrome—Varenicline—nicotine dependence	0.00309	0.00527	CcSEcCtD
Tretinoin—Myocardial infarction—Varenicline—nicotine dependence	0.00307	0.00524	CcSEcCtD
Tretinoin—Stomatitis—Varenicline—nicotine dependence	0.00305	0.00521	CcSEcCtD
Tretinoin—Conjunctivitis—Varenicline—nicotine dependence	0.00305	0.0052	CcSEcCtD
Tretinoin—Epistaxis—Varenicline—nicotine dependence	0.00295	0.00504	CcSEcCtD
Tretinoin—Sinusitis—Varenicline—nicotine dependence	0.00294	0.00502	CcSEcCtD
Tretinoin—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00291	0.012	CbGpPWpGaD
Tretinoin—CYP3A7—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00288	0.0119	CbGpPWpGaD
Tretinoin—Hypoaesthesia—Varenicline—nicotine dependence	0.0028	0.00478	CcSEcCtD
Tretinoin—Hallucination—Varenicline—nicotine dependence	0.0028	0.00478	CcSEcCtD
Tretinoin—Urinary tract disorder—Varenicline—nicotine dependence	0.00278	0.00474	CcSEcCtD
Tretinoin—Oedema peripheral—Varenicline—nicotine dependence	0.00277	0.00473	CcSEcCtD
Tretinoin—Urethral disorder—Varenicline—nicotine dependence	0.00276	0.00471	CcSEcCtD
Tretinoin—Visual impairment—Varenicline—nicotine dependence	0.00271	0.00463	CcSEcCtD
Tretinoin—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00267	0.011	CbGpPWpGaD
Tretinoin—Erythema multiforme—Varenicline—nicotine dependence	0.00266	0.00454	CcSEcCtD
Tretinoin—CYP2A6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00264	0.0109	CbGpPWpGaD
Tretinoin—Eye disorder—Varenicline—nicotine dependence	0.00263	0.00449	CcSEcCtD
Tretinoin—Tinnitus—Varenicline—nicotine dependence	0.00262	0.00448	CcSEcCtD
Tretinoin—RXRA—Orphan transporters—GABRA4—nicotine dependence	0.00256	0.0106	CbGpPWpGaD
Tretinoin—Angiopathy—Varenicline—nicotine dependence	0.00255	0.00436	CcSEcCtD
Tretinoin—Chills—Varenicline—nicotine dependence	0.00252	0.00431	CcSEcCtD
Tretinoin—Arrhythmia—Varenicline—nicotine dependence	0.00251	0.00429	CcSEcCtD
Tretinoin—Mental disorder—Varenicline—nicotine dependence	0.00246	0.00421	CcSEcCtD
Tretinoin—Erythema—Varenicline—nicotine dependence	0.00245	0.00418	CcSEcCtD
Tretinoin—Malnutrition—Varenicline—nicotine dependence	0.00245	0.00418	CcSEcCtD
Tretinoin—Flatulence—Varenicline—nicotine dependence	0.00241	0.00412	CcSEcCtD
Tretinoin—Back pain—Varenicline—nicotine dependence	0.00237	0.00404	CcSEcCtD
Tretinoin—CYP3A7—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00236	0.00974	CbGpPWpGaD
Tretinoin—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00236	0.00973	CbGpPWpGaD
Tretinoin—Vision blurred—Varenicline—nicotine dependence	0.00231	0.00394	CcSEcCtD
Tretinoin—Tremor—Varenicline—nicotine dependence	0.00229	0.00392	CcSEcCtD
Tretinoin—Ill-defined disorder—Varenicline—nicotine dependence	0.00227	0.00388	CcSEcCtD
Tretinoin—Anaemia—Varenicline—nicotine dependence	0.00226	0.00386	CcSEcCtD
Tretinoin—Agitation—Varenicline—nicotine dependence	0.00225	0.00384	CcSEcCtD
Tretinoin—Malaise—Varenicline—nicotine dependence	0.00221	0.00377	CcSEcCtD
Tretinoin—Syncope—Varenicline—nicotine dependence	0.0022	0.00375	CcSEcCtD
Tretinoin—CYP2A6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00217	0.00893	CbGpPWpGaD
Tretinoin—Palpitations—Varenicline—nicotine dependence	0.00216	0.00369	CcSEcCtD
Tretinoin—CYP4A11—Biological oxidations—CYP2A7—nicotine dependence	0.00216	0.00891	CbGpPWpGaD
Tretinoin—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00216	0.00889	CbGpPWpGaD
Tretinoin—Loss of consciousness—Varenicline—nicotine dependence	0.00215	0.00367	CcSEcCtD
Tretinoin—Cough—Varenicline—nicotine dependence	0.00214	0.00365	CcSEcCtD
Tretinoin—CYP2B6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00213	0.00877	CbGpPWpGaD
Tretinoin—Convulsion—Varenicline—nicotine dependence	0.00212	0.00362	CcSEcCtD
Tretinoin—Hypertension—Varenicline—nicotine dependence	0.00211	0.00361	CcSEcCtD
Tretinoin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00211	0.00869	CbGpPWpGaD
Tretinoin—Myalgia—Varenicline—nicotine dependence	0.00208	0.00356	CcSEcCtD
Tretinoin—Arthralgia—Varenicline—nicotine dependence	0.00208	0.00356	CcSEcCtD
Tretinoin—Chest pain—Varenicline—nicotine dependence	0.00208	0.00356	CcSEcCtD
Tretinoin—CYP3A5—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00208	0.00857	CbGpPWpGaD
Tretinoin—Anxiety—Varenicline—nicotine dependence	0.00208	0.00355	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00207	0.00353	CcSEcCtD
Tretinoin—Discomfort—Varenicline—nicotine dependence	0.00206	0.00352	CcSEcCtD
Tretinoin—Dry mouth—Varenicline—nicotine dependence	0.00204	0.00348	CcSEcCtD
Tretinoin—CYP2C18—Metapathway biotransformation—AKR1B10—nicotine dependence	0.002	0.00826	CbGpPWpGaD
Tretinoin—Oedema—Varenicline—nicotine dependence	0.002	0.00341	CcSEcCtD
Tretinoin—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00199	0.00821	CbGpPWpGaD
Tretinoin—Infection—Varenicline—nicotine dependence	0.00198	0.00339	CcSEcCtD
Tretinoin—Shock—Varenicline—nicotine dependence	0.00197	0.00336	CcSEcCtD
Tretinoin—CYP1A1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00196	0.0081	CbGpPWpGaD
Tretinoin—Nervous system disorder—Varenicline—nicotine dependence	0.00196	0.00335	CcSEcCtD
Tretinoin—Thrombocytopenia—Varenicline—nicotine dependence	0.00196	0.00334	CcSEcCtD
Tretinoin—Tachycardia—Varenicline—nicotine dependence	0.00195	0.00333	CcSEcCtD
Tretinoin—Skin disorder—Varenicline—nicotine dependence	0.00194	0.00331	CcSEcCtD
Tretinoin—Hyperhidrosis—Varenicline—nicotine dependence	0.00193	0.0033	CcSEcCtD
Tretinoin—CYP2C8—brain—nicotine dependence	0.00191	0.0111	CbGeAlD
Tretinoin—Anorexia—Varenicline—nicotine dependence	0.0019	0.00325	CcSEcCtD
Tretinoin—CYP2C18—Biological oxidations—CYP2A7—nicotine dependence	0.00189	0.00779	CbGpPWpGaD
Tretinoin—Hypotension—Varenicline—nicotine dependence	0.00187	0.00319	CcSEcCtD
Tretinoin—CYP2C18—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00186	0.00768	CbGpPWpGaD
Tretinoin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00182	0.00752	CbGpPWpGaD
Tretinoin—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00182	0.00311	CcSEcCtD
Tretinoin—Insomnia—Varenicline—nicotine dependence	0.00181	0.00309	CcSEcCtD
Tretinoin—CYP2C8—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0018	0.00743	CbGpPWpGaD
Tretinoin—Dyspnoea—Varenicline—nicotine dependence	0.00178	0.00304	CcSEcCtD
Tretinoin—Somnolence—Varenicline—nicotine dependence	0.00178	0.00303	CcSEcCtD
Tretinoin—CYP1A1—brain—nicotine dependence	0.00177	0.0103	CbGeAlD
Tretinoin—Dyspepsia—Varenicline—nicotine dependence	0.00176	0.003	CcSEcCtD
Tretinoin—CYP2B6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00175	0.00721	CbGpPWpGaD
Tretinoin—Decreased appetite—Varenicline—nicotine dependence	0.00174	0.00297	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00172	0.00295	CcSEcCtD
Tretinoin—Fatigue—Varenicline—nicotine dependence	0.00172	0.00294	CcSEcCtD
Tretinoin—CYP2B6—brain—nicotine dependence	0.00172	0.00999	CbGeAlD
Tretinoin—RXRA—Biological oxidations—CYP2A7—nicotine dependence	0.00171	0.00706	CbGpPWpGaD
Tretinoin—Constipation—Varenicline—nicotine dependence	0.00171	0.00292	CcSEcCtD
Tretinoin—Pain—Varenicline—nicotine dependence	0.00171	0.00292	CcSEcCtD
Tretinoin—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00171	0.00704	CbGpPWpGaD
Tretinoin—Feeling abnormal—Varenicline—nicotine dependence	0.00165	0.00281	CcSEcCtD
Tretinoin—Gastrointestinal pain—Varenicline—nicotine dependence	0.00163	0.00279	CcSEcCtD
Tretinoin—NR0B1—Gene Expression—CCAR1—nicotine dependence	0.00162	0.00667	CbGpPWpGaD
Tretinoin—CYP1A1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00161	0.00665	CbGpPWpGaD
Tretinoin—Urticaria—Varenicline—nicotine dependence	0.00159	0.00271	CcSEcCtD
Tretinoin—Abdominal pain—Varenicline—nicotine dependence	0.00158	0.0027	CcSEcCtD
Tretinoin—Body temperature increased—Varenicline—nicotine dependence	0.00158	0.0027	CcSEcCtD
Tretinoin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00149	0.00612	CbGpPWpGaD
Tretinoin—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00148	0.0061	CbGpPWpGaD
Tretinoin—Hypersensitivity—Varenicline—nicotine dependence	0.00147	0.00251	CcSEcCtD
Tretinoin—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00147	0.00604	CbGpPWpGaD
Tretinoin—Asthenia—Varenicline—nicotine dependence	0.00143	0.00245	CcSEcCtD
Tretinoin—Pruritus—Varenicline—nicotine dependence	0.00141	0.00241	CcSEcCtD
Tretinoin—Diarrhoea—Varenicline—nicotine dependence	0.00137	0.00233	CcSEcCtD
Tretinoin—CYP3A7—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00133	0.00549	CbGpPWpGaD
Tretinoin—Dizziness—Varenicline—nicotine dependence	0.00132	0.00226	CcSEcCtD
Tretinoin—RARG—Gene Expression—CCAR1—nicotine dependence	0.0013	0.00538	CbGpPWpGaD
Tretinoin—Vomiting—Varenicline—nicotine dependence	0.00127	0.00217	CcSEcCtD
Tretinoin—Rash—Varenicline—nicotine dependence	0.00126	0.00215	CcSEcCtD
Tretinoin—Dermatitis—Varenicline—nicotine dependence	0.00126	0.00215	CcSEcCtD
Tretinoin—CYP3A7—Biological oxidations—CYP2A7—nicotine dependence	0.00125	0.00518	CbGpPWpGaD
Tretinoin—Headache—Varenicline—nicotine dependence	0.00125	0.00214	CcSEcCtD
Tretinoin—CYP3A7—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00124	0.0051	CbGpPWpGaD
Tretinoin—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0012	0.00496	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—CCAR1—nicotine dependence	0.00119	0.00492	CbGpPWpGaD
Tretinoin—Nausea—Varenicline—nicotine dependence	0.00119	0.00203	CcSEcCtD
Tretinoin—RARB—Gene Expression—CCAR1—nicotine dependence	0.00117	0.00483	CbGpPWpGaD
Tretinoin—CYP2A6—Biological oxidations—CYP2A7—nicotine dependence	0.00115	0.00474	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—CCAR1—nicotine dependence	0.00112	0.00463	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—CCAR1—nicotine dependence	0.00112	0.00463	CbGpPWpGaD
Tretinoin—CYP2B6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000985	0.00406	CbGpPWpGaD
Tretinoin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000979	0.00404	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—CYP2A7—nicotine dependence	0.000968	0.00399	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—CYP2A7—nicotine dependence	0.000968	0.00399	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—CYP2A7—nicotine dependence	0.000968	0.00399	CbGpPWpGaD
Tretinoin—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000967	0.00399	CbGpPWpGaD
Tretinoin—CYP3A5—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000962	0.00397	CbGpPWpGaD
Tretinoin—CYP2B6—Biological oxidations—CYP2A7—nicotine dependence	0.000928	0.00383	CbGpPWpGaD
Tretinoin—CYP2B6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000915	0.00377	CbGpPWpGaD
Tretinoin—CYP1A1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000909	0.00375	CbGpPWpGaD
Tretinoin—CYP3A5—Biological oxidations—CYP2A7—nicotine dependence	0.000907	0.00374	CbGpPWpGaD
Tretinoin—CYP3A5—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000895	0.00369	CbGpPWpGaD
Tretinoin—CYP1A1—Biological oxidations—CYP2A7—nicotine dependence	0.000857	0.00353	CbGpPWpGaD
Tretinoin—CYP1A1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000845	0.00349	CbGpPWpGaD
Tretinoin—CYP2C8—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000834	0.00344	CbGpPWpGaD
Tretinoin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000794	0.00327	CbGpPWpGaD
Tretinoin—CYP2C8—Biological oxidations—CYP2A7—nicotine dependence	0.000786	0.00324	CbGpPWpGaD
Tretinoin—CYP2C8—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000775	0.0032	CbGpPWpGaD
Tretinoin—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000678	0.0028	CbGpPWpGaD
Tretinoin—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.000639	0.00264	CbGpPWpGaD
Tretinoin—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000631	0.0026	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000625	0.00258	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—CCAR1—nicotine dependence	0.000585	0.00241	CbGpPWpGaD
Tretinoin—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000447	0.00185	CbGpPWpGaD
Tretinoin—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000422	0.00174	CbGpPWpGaD
Tretinoin—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000416	0.00172	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—CYP2A7—nicotine dependence	0.000369	0.00152	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—CYP2A7—nicotine dependence	0.000323	0.00133	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—CYP2A7—nicotine dependence	0.000293	0.00121	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CYP2A7—nicotine dependence	0.000215	0.000885	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CYP2A7—nicotine dependence	0.000197	0.000811	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CYP2A7—nicotine dependence	0.000159	0.000655	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CYP2A7—nicotine dependence	0.000155	0.00064	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CYP2A7—nicotine dependence	0.000147	0.000604	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CYP2A7—nicotine dependence	0.000134	0.000554	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP2A7—nicotine dependence	0.000109	0.000451	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP2A7—nicotine dependence	7.21e-05	0.000297	CbGpPWpGaD
